Active, Not Recruiting
A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors
NCT03843359
- Conditions
- Bites and Stings, Chemically-Induced Disorders, Neoplasms, +2 more
- Locations
-
- GSK Investigational Site Houston, Texas, United States
- GSK Investigational Site Melbourne, Victoria, Australia
- GSK Investigational Site Toronto, Ontario, Canada
- GSK Investigational Site Bordeaux, France